Month: April 2026
This insider says reclassification could revitalize Arizona’s medical marijuana industry
The Trump administration has reclassified medical marijuana — moving it from a Schedule I to a Schedule III drug.
Federal marijuana reclassification could expand research, ease tax burden for cannabis businesses
The change could also bring financial relief to the cannabis industry, which has long faced heavy tax burdens under federal…
WA dispensaries celebrate federal reclassification of medical marijuana
We see a lot of businesses that are really struggling right now, that just really aren’t profitable.” On Thursday, the…
Does Cannabis Legalization Spur More Innovation Than Medical Research?
The rescheduling of medical cannabis marks one of the most significant U.S. drug policy shifts in years, potentially easing barriers…
Colorado business owners say marijuana reclassification could create new opportunities
A major shift in federal marijuana policy could soon change how cannabis and some CBD businesses operate across Colorado.
What the Trump administration’s federal marijuana change means for Kentucky
The federal government made a new change this week to how marijuana is defined, but it doesn’t yet mean the…
Medical marijuana rescheduled by Feds, could open up research and tax breaks
The U.S. Justice Department ordered the immediate placement of medical marijuana into a lower, less restrictive tier of regulated drugs…
Trump turns over new leaf in GOP drug policy with marijuana, psychedelics orders
The Trump administration’s moves on marijuana and psychedelics signal the start of a new era in Republican drug policy. The…
Canopy Growth Is Rallying Again. But Is It a Dead Cat Bounce?
Canopy Growth (NASDAQ: CGC) is a Canadian marijuana company. When it first came public marijuana was a hot sector, but…
Local cannabis industry applauds loosening federal regulation
Medical marijuana researchers and business owners across western Pennsylvania will see relief from some federal regulation thanks to a change…
Recent Comments